Issues
-
Cover Image
Cover Image
Fundamental to understanding leukemia pathogenesis and relapse is the concept of the leukemia stem cell (LSC) as the leukemia-initiating cell at the top of the differentiation hierarchy. Papapetrou and colleagues extend this concept to not one but many LSCs sequentially contributing to the disease. The authors develop a framework of LSC generation and evolution through three dimensions: developmental ontogeny, genetic lesions, and differentiation hierarchy. Studying myeloid transformation through these three dimensions across time is essential to understanding its pathogenesis and heterogeneity. For more information, see the article on page 94. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
In This Issue
Reviews
Research Brief
Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation
Hematopoietic cell transplantation and graft age independently contribute to clonal hematopoiesis in long-term pediatric survivors.
Research Article
Dynamics of Immune Reconstitution and Impact on Outcomes across CAR-T Cell Products in Large B-cell Lymphoma
Early NK cell recovery is associated with favorable clinical responses to CART in lymphoma.
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.